A detailed history of Schechter Investment Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 34,285 shares of SNY stock, worth $1.66 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
34,285
Previous 36,075 4.96%
Holding current value
$1.66 Million
Previous $1.75 Million 12.91%
% of portfolio
0.2%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$48.54 - $58.53 $86,886 - $104,768
-1,790 Reduced 4.96%
34,285 $1.98 Million
Q2 2024

Aug 12, 2024

SELL
$45.39 - $50.36 $553,031 - $613,586
-12,184 Reduced 25.25%
36,075 $1.75 Million
Q1 2024

May 06, 2024

BUY
$45.75 - $52.48 $137,387 - $157,597
3,003 Added 6.64%
48,259 $2.35 Million
Q4 2023

Jan 17, 2024

BUY
$43.13 - $54.79 $111,836 - $142,070
2,593 Added 6.08%
45,256 $2.25 Million
Q3 2023

Nov 06, 2023

SELL
$50.95 - $55.2 $59,051 - $63,976
-1,159 Reduced 2.64%
42,663 $2.29 Million
Q2 2023

Jul 26, 2023

SELL
$50.45 - $57.18 $307,795 - $348,855
-6,101 Reduced 12.22%
43,822 $2.36 Million
Q1 2023

Apr 28, 2023

BUY
$45.86 - $54.45 $94,884 - $112,657
2,069 Added 4.32%
49,923 $2.72 Million
Q4 2022

Feb 13, 2023

BUY
$38.86 - $48.55 $53,160 - $66,416
1,368 Added 2.94%
47,854 $2.32 Million
Q3 2022

Nov 04, 2022

SELL
$37.22 - $100.5 $649,526 - $1.75 Million
-17,451 Reduced 27.29%
46,486 $1.77 Million
Q2 2022

Nov 03, 2022

BUY
$48.99 - $57.46 $3.13 Million - $3.67 Million
63,937 New
63,937 $3.2 Million
Q1 2022

Nov 18, 2022

BUY
$48.48 - $53.65 $849,030 - $939,572
17,513 Added 37.67%
63,999 $3.29 Million
Q4 2021

Dec 27, 2022

BUY
$47.07 - $52.35 $734,715 - $817,131
15,609 Added 33.58%
62,095 $3.11 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.